Innovita Biological Technology Co., Ltd. (SHA:688253)
China · Delayed Price · Currency is CNY 31.78
+1.03 (3.35%)
At close: Oct 31, 2025
SHA:688253 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Net Income | 133.44 | 246.86 | 173.95 | 150.68 | 120.25 | 571.45 | Upgrade |
Depreciation & Amortization | 21.67 | 21.71 | 25.46 | 19.06 | 13.21 | 5.4 | Upgrade |
Other Amortization | 8.02 | 7.98 | 7.46 | 6.66 | 5.89 | 1.17 | Upgrade |
Loss (Gain) From Sale of Assets | -0.01 | -0.01 | -0 | -0.01 | - | - | Upgrade |
Asset Writedown & Restructuring Costs | 0.11 | 0.11 | 19.54 | - | 0.61 | 0.59 | Upgrade |
Loss (Gain) From Sale of Investments | -32.03 | -32.03 | -26.08 | -7.09 | -2.46 | -3.53 | Upgrade |
Provision & Write-off of Bad Debts | 4.04 | 4.04 | 4.91 | 6.17 | - | 0.03 | Upgrade |
Other Operating Activities | -7.12 | 7.97 | 25.51 | 1.6 | 0.04 | 0.53 | Upgrade |
Change in Accounts Receivable | 47.27 | 47.27 | 48.71 | -193.74 | 18.62 | 9.08 | Upgrade |
Change in Inventory | 14.01 | 14.01 | -12.42 | -31.83 | -6.13 | -26.01 | Upgrade |
Change in Accounts Payable | -9.46 | -9.46 | 0.37 | 174.7 | -44.3 | 53.88 | Upgrade |
Change in Other Net Operating Assets | 6.15 | 6.15 | 1.72 | - | - | 26.6 | Upgrade |
Operating Cash Flow | 176.95 | 305.46 | 259.85 | 126.43 | 106.27 | 639.82 | Upgrade |
Operating Cash Flow Growth | -59.09% | 17.55% | 105.53% | 18.97% | -83.39% | 1728.56% | Upgrade |
Capital Expenditures | -39.92 | -36.16 | -16.97 | -57.71 | -63.75 | -76.71 | Upgrade |
Sale of Property, Plant & Equipment | 0.28 | 0.26 | 0 | - | 0 | 0 | Upgrade |
Investment in Securities | -291.68 | -26.11 | -410.95 | -1,037 | 22.78 | -77.73 | Upgrade |
Other Investing Activities | -6.45 | -1 | - | 8.82 | 1.7 | 3.99 | Upgrade |
Investing Cash Flow | -338.9 | -63.01 | -428.92 | -1,086 | -39.27 | -150.45 | Upgrade |
Short-Term Debt Issued | - | - | - | 17.57 | - | 13.29 | Upgrade |
Total Debt Issued | - | - | - | 17.57 | - | 13.29 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | -8.29 | -5 | Upgrade |
Long-Term Debt Repaid | - | -3.55 | -20.83 | -3.05 | -1.19 | - | Upgrade |
Total Debt Repaid | -3.55 | -3.55 | -20.83 | -3.05 | -9.48 | -5 | Upgrade |
Net Debt Issued (Repaid) | -3.55 | -3.55 | -20.83 | 14.52 | -9.48 | 8.29 | Upgrade |
Issuance of Common Stock | 6.66 | 5.25 | - | 820.07 | - | 55.2 | Upgrade |
Common Dividends Paid | -75.23 | -54.42 | -22.64 | -0.22 | -50.07 | -100.29 | Upgrade |
Other Financing Activities | -77.57 | -50.01 | -1 | -18.59 | - | - | Upgrade |
Financing Cash Flow | -149.7 | -102.74 | -44.48 | 815.78 | -59.55 | -36.81 | Upgrade |
Foreign Exchange Rate Adjustments | 1.77 | 1.56 | 1.33 | 42.65 | -9.76 | -31.26 | Upgrade |
Net Cash Flow | -309.88 | 141.27 | -212.21 | -101.07 | -2.3 | 421.3 | Upgrade |
Free Cash Flow | 137.04 | 269.31 | 242.89 | 68.71 | 42.52 | 563.1 | Upgrade |
Free Cash Flow Growth | -66.26% | 10.88% | 253.47% | 61.59% | -92.45% | 2177.86% | Upgrade |
Free Cash Flow Margin | 31.80% | 43.34% | 50.81% | 15.38% | 13.01% | 54.30% | Upgrade |
Free Cash Flow Per Share | 1.00 | 1.98 | 1.79 | 0.56 | 0.42 | 5.69 | Upgrade |
Cash Income Tax Paid | 50.98 | 90.94 | 45.98 | 33.76 | 42.72 | 145.54 | Upgrade |
Levered Free Cash Flow | 92.21 | 213.46 | 178.62 | 44.72 | -7.06 | 398.81 | Upgrade |
Unlevered Free Cash Flow | 92.23 | 213.54 | 178.75 | 44.97 | -6.98 | 398.92 | Upgrade |
Change in Working Capital | 48.84 | 48.84 | 29.1 | -50.64 | -31.28 | 64.17 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.